Multiple Myeloma

Showing NaN - NaN of 79

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Pom/dex (Pomalidomide plus low dose Dexamethasone))

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • Pom/dex (Pomalidomide plus low dose Dexamethasone)
  • Tucson, Arizona
  • +163 more
Feb 25, 2022

Multiple Myeloma Trial in Worldwide (Daratumumab, Bortezomib, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • Adelaide, Australia
  • +51 more
Feb 16, 2022

Presentation, Treatment Patterns, and Outcomes in Multiple

Completed
  • Multiple Myeloma
  • No Intervention
  • Little Rock, Arkansas
  • +136 more
Feb 15, 2022

Multiple Myeloma Trial in Worldwide (Melphalan flufenamide (Melflufen), Dexamethasone)

Completed
  • Multiple Myeloma
  • Whittier, California
  • +19 more
Feb 2, 2022

Multiple Myeloma Trial in Spain (Clarithromycin, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • A Coruña, Spain
  • +25 more
Jan 17, 2022

Multiple Myeloma Trial in Worldwide (Elotuzumab, Pomalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • Atlanta, Georgia
  • +54 more
Jan 11, 2022

Multiple Myeloma Trial in Spain (Belantamab mafodotin, Bortezomib, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • +4 more
  • Sevilla, Andalucia, Spain
  • +17 more
Dec 3, 2021

Biological Relapse in Patients With Multiple Myeloma

Terminated
  • Multiple Myeloma
    • Zaragoza, Aragón, Spain
    • +43 more
    Sep 7, 2021

    Multiple Myeloma Trial in Worldwide (Pomalidomide and Dexamethasone)

    Completed
    • Multiple Myeloma
    • Pomalidomide and Dexamethasone
    • Linz, Austria
    • +21 more
    Aug 25, 2021

    Assess Disease Burden, in Terms of Health-related Quality of

    Active, not recruiting
    • Multiple Myeloma
      • Algeciras, Andalusia, Spain
      • +64 more
      Aug 18, 2021

      Treatment in Relapsed Multiple Myeloma and Creatinine Clearance

      Completed
      • Multiple Myeloma
      • Anti-myeloma treatment at physician discretion
      • Jaen, Andalucia, Spain
      • +39 more
      Aug 12, 2021

      Multiple Myeloma Trial in Worldwide (Durvalumab, Pomalidomide, Dexamethasone)

      Active, not recruiting
      • Multiple Myeloma
      • Little Rock, Arkansas
      • +34 more
      Aug 4, 2021

      Multiple Myeloma Trial in Worldwide (LBH589, Lenalidomide)

      Completed
      • Multiple Myeloma
      • San Francisco, California
      • +9 more
      Dec 16, 2020

      Multiple Myeloma, Renal Insufficiency Trial in Spain, United Kingdom, United States (BHQ880, BHQ880 Placebo, bortezomib)

      Completed
      • Multiple Myeloma
      • Renal Insufficiency
      • Chicago, Illinois
      • +7 more
      Dec 11, 2020

      Multiple Myeloma Symptomatic Relapse and/or Refractory Disease

      Completed
      • Multiple Myeloma
      • No Intervention
      • Cadiz, Andalucia, Spain
      • +29 more
      Sep 14, 2020

      Multiple Myeloma Trial in France, Spain (Plitidepsin, Bortezomib, Dexamethasone)

      Completed
      • Multiple Myeloma
      • Villejuif, France
      • +6 more
      Sep 17, 2020

      Multiple Myeloma Trial in Spain (Pembrolizumab)

      Completed
      • Multiple Myeloma
      • Badalona, Spain
      • +10 more
      Apr 28, 2020

      Multiple Myeloma Trial in Spain (zoledronic acid, No treatment control)

      Completed
      • Multiple Myeloma
      • zoledronic acid
      • No treatment control
      • Badalona, Spain
      • +15 more
      Apr 3, 2020

      Multiple Myeloma Trial in Worldwide (Panobinostat, Bortezomib, Dexamethasone)

      Completed
      • Multiple Myeloma
      • Phoenix, Arizona
      • +209 more
      Mar 8, 2020

      Multiple Myeloma Trial in Worldwide (Ibrutinib, Bortezomib, Dexamethasone)

      Completed
      • Multiple Myeloma
      • Brno, Czechia
      • +32 more
      Mar 2, 2020

      Multiple Myeloma Trial in Worldwide (Ibrutinib, Pomalidomide, Dexamethasone)

      Terminated
      • Multiple Myeloma
      • Duarte, California
      • +15 more
      Nov 4, 2019

      Multiple Myeloma Trial in Worldwide (Lenalidomide and low-dose dexamethasone, Lenalidomide plus low-dose dexamethasone given for

      Completed
      • Multiple Myeloma
      • Lenalidomide and low-dose dexamethasone
      • +2 more
      • Birmingham, Alabama
      • +287 more
      Nov 7, 2019

      Multiple Myeloma Trial in Worldwide (pomalidomide)

      Completed
      • Multiple Myeloma
      • Adelaide, Australia
      • +90 more
      Nov 7, 2019